BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38100120)

  • 1. ARID1A loss induces P4HB to activate fibroblasts to support lung cancer cell growth, invasion, and chemoresistance.
    Huang R; Wu D; Zhang K; Hu G; Liu Y; Jiang Y; Wang C; Zheng Y
    Cancer Sci; 2024 Feb; 115(2):439-451. PubMed ID: 38100120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
    Yang W; Wu X; Zhou F
    Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
    Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
    Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLAU promotes growth and attenuates cisplatin chemosensitivity in ARID1A-depleted non-small cell lung cancer through interaction with TM4SF1.
    Zheng Y; Zhang L; Zhang K; Wu S; Wang C; Huang R; Liao H
    Biol Direct; 2024 Jan; 19(1):7. PubMed ID: 38229120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.
    Zhou Y; Yang J; Zhang Q; Xu Q; Lu L; Wang J; Xia W
    Mol Med Rep; 2019 Jan; 19(1):231-237. PubMed ID: 30431122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines.
    Wang SM; Lin LZ; Zhou DH; Zhou JX; Xiong SQ
    Chin J Integr Med; 2015 Sep; 21(9):689-96. PubMed ID: 24382781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
    Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang J; Guo S; Wu Y; Zheng ZC; Wang Y; Zhao Y
    Biomed Res Int; 2019; 2019():9749751. PubMed ID: 31467922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation analysis of efficacy of yiqi chutan recipe in treating NSCLC and P4HB expression].
    Sun LL; Lin LZ; Zhou JX; Chen ZZ; Tao WH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):184-7. PubMed ID: 25881463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
    Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
    BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
    Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
    Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.
    Xia W; Zhuang J; Wang G; Ni J; Wang J; Ye Y
    Oncotarget; 2017 Jan; 8(5):8512-8521. PubMed ID: 28052026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.
    Luo Q; Wu X; Chang W; Zhao P; Zhu X; Chen H; Nan Y; Luo A; Zhou X; Su D; Jiao W; Liu Z
    Cancer Res; 2020 Feb; 80(3):406-417. PubMed ID: 32015157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
    Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
    Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH/Bcl-2/caspase-3 pathway.
    Gao X; Wang Y; Lu F; Chen X; Yang D; Cao Y; Zhang W; Chen J; Zheng L; Wang G; Fu M; Ma L; Song Y; Zhan Q
    J Extracell Vesicles; 2021 Mar; 10(5):e12060. PubMed ID: 33732415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
    Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
    Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
    Sun X; Wang SC; Wei Y; Luo X; Jia Y; Li L; Gopal P; Zhu M; Nassour I; Chuang JC; Maples T; Celen C; Nguyen LH; Wu L; Fu S; Li W; Hui L; Tian F; Ji Y; Zhang S; Sorouri M; Hwang TH; Letzig L; James L; Wang Z; Yopp AC; Singal AG; Zhu H
    Cancer Cell; 2017 Nov; 32(5):574-589.e6. PubMed ID: 29136504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbate starvation alters endoplasmic reticulum-resident enzymes in cardiac fibroblasts, priming them for increased procollagen secretion.
    Cowling RT; Park JI; Sotimehin AE; Greenberg BH
    J Mol Cell Cardiol; 2017 Dec; 113():1-8. PubMed ID: 28923350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
    Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
    Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.